2026 Peutz-Jeghers syndrome indication strategy covering epidemiology, STK11 biology, active trials, transactions, unmet need, competition and market attractiveness.

2026 Blue rubber bleb nevus syndrome indication strategy covering epidemiology, TEK biology, active trials, transactions, unmet need, competition and market…

2026 Intestinal Behcet disease indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market…

2026 Radiation proctitis indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and market attractiveness.

2026 Diversion colitis indication strategy covering epidemiology, PPAR-gamma biology, active trials, transactions, unmet need, competition and market attractiveness.

2026 Chronic antibiotic-refractory pouchitis indication strategy covering epidemiology, IL-23 biology, active trials, transactions, unmet need, competition and…

2026 Pancreaticopleural fistula indication strategy covering epidemiology, Somatostatin receptor biology, active trials, transactions, unmet need, competition…

2026 Pancreatic ascites indication strategy covering epidemiology, Somatostatin receptor biology, active trials, transactions, unmet need, competition and market…

2026 Tropical chronic pancreatitis indication strategy covering epidemiology, CFTR biology, active trials, transactions, unmet need, competition and market…

2026 Pancreatic exocrine insufficiency indication strategy covering epidemiology, CFTR biology, active trials, transactions, unmet need, competition and market…

2026 Recurrent acute pancreatitis indication strategy covering epidemiology, TRPV1 biology, active trials, transactions, unmet need, competition and market…

2026 Hereditary pancreatitis indication strategy covering epidemiology, PRSS1 biology, active trials, transactions, unmet need, competition and market…